These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24635554)

  • 21. Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye.
    Sigurdsson HH; Konráethsdóttir F; Loftsson T; Stefánsson E
    Acta Ophthalmol Scand; 2007 Sep; 85(6):598-602. PubMed ID: 17645424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Progress in sustained-release drug delivery system for treatment of posterior segment eye diseases].
    Sun SM; Cheng LY
    Zhonghua Yan Ke Za Zhi; 2013 Sep; 49(9):847-50. PubMed ID: 24330936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Miconazole mucoadhesive tablets: a novel delivery system.
    Vazquez JA; Sobel JD
    Clin Infect Dis; 2012 May; 54(10):1480-4. PubMed ID: 22495075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases.
    Bachu RD; Chowdhury P; Al-Saedi ZHF; Karla PK; Boddu SHS
    Pharmaceutics; 2018 Feb; 10(1):. PubMed ID: 29495528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solid lipid nanoparticles for ocular drug delivery.
    Seyfoddin A; Shaw J; Al-Kassas R
    Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanotechnology in ocular drug delivery.
    Sahoo SK; Dilnawaz F; Krishnakumar S
    Drug Discov Today; 2008 Feb; 13(3-4):144-51. PubMed ID: 18275912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of HPMC concentration on release of theophylline or hydrocortisone from extended release mini-tablets.
    Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2013 Aug; 39(8):1167-74. PubMed ID: 22540355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advancements in ocular drug delivery.
    Weiner AL; Gilger BC
    Vet Ophthalmol; 2010 Nov; 13(6):395-406. PubMed ID: 21182726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implants for drug delivery to the posterior segment of the eye: a focus on stimuli-responsive and tunable release systems.
    Yasin MN; Svirskis D; Seyfoddin A; Rupenthal ID
    J Control Release; 2014 Dec; 196():208-21. PubMed ID: 25307997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the in vivo behaviour of gentamicin sulphate ocular mini-tablets in ponies.
    Gasthuys F; Pockelé K; Vervaet C; Weyenberg W; De Prijck K; Pille F; Vlaminck L; Nelis H; Remon JP
    J Vet Pharmacol Ther; 2007 Oct; 30(5):470-6. PubMed ID: 17803741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Orally disintegrating films and mini-tablets-innovative dosage forms of choice for pediatric use.
    Preis M
    AAPS PharmSciTech; 2015 Apr; 16(2):234-41. PubMed ID: 25739913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations.
    Loftsson T; Sigurdsson HH; Konrádsdóttir F; Gísladóttir S; Jansook P; Stefánsson E
    Pharmazie; 2008 Mar; 63(3):171-9. PubMed ID: 18444504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug delivery systems for the eye.
    Kearns VR; Williams RL
    Expert Rev Med Devices; 2009 May; 6(3):277-90. PubMed ID: 19419285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of the clinical applications of drug delivery systems for the treatment of ocular anterior segment inflammation.
    Wong CW; Metselaar JM; Storm G; Wong TT
    Br J Ophthalmol; 2021 Dec; 105(12):1617-1622. PubMed ID: 33127826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.
    Myles ME; Neumann DM; Hill JM
    Adv Drug Deliv Rev; 2005 Dec; 57(14):2063-79. PubMed ID: 16310884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioerodible polymers for ocular drug delivery.
    Deshpande AA; Heller J; Gurny R
    Crit Rev Ther Drug Carrier Syst; 1998; 15(4):381-420. PubMed ID: 9736417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocular drug delivery to the anterior segment using nanocarriers: A mucoadhesive/mucopenetrative perspective.
    Dave RS; Goostrey TC; Ziolkowska M; Czerny-Holownia S; Hoare T; Sheardown H
    J Control Release; 2021 Aug; 336():71-88. PubMed ID: 34119558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optical fiber-coupled ocular spectrometer for measurement of drug concentration in the anterior eye--applications in pharmaceuticals research.
    Miller J; Wilson WS; Blue R; Wilson CG; Uttamchandani D
    IEEE Trans Biomed Eng; 2010 Dec; 57(12):2903-9. PubMed ID: 20656650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microspheres and Nanotechnology for Drug Delivery.
    Jóhannesson G; Stefánsson E; Loftsson T
    Dev Ophthalmol; 2016; 55():93-103. PubMed ID: 26501994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety evaluation of ocular drug delivery formulations: techniques and practical considerations.
    Short BG
    Toxicol Pathol; 2008 Jan; 36(1):49-62. PubMed ID: 18337221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.